You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neovascular AMD (nvAMD)

Showing 1 - 25 of 1,075
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

Recruiting
  • Neovascular Age-related Macular Degeneration (NVAMD)
  • Diabetic Macular Edema (DME)
  • Phoenix, Arizona
  • +4 more
Jun 14, 2023

Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
  • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
  • (no location specified)
Jun 6, 2023

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Subjects Diagnosed With Neovascular-AMD

Recruiting
  • Retinal Neovascularization
    • Boston, Massachusetts
    • +2 more
    Dec 6, 2022

    Age-Related Macular Degeneration Trial (KH631)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • (no location specified)
    Dec 10, 2022

    Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

    Recruiting
    • Age-Related Macular Degeneration
    • Hong Kong, Hong Kong
      Grantham Hospital
    Jan 25, 2023

    Neovascular Age-related Macular Degeneration Trial (FT-003)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • FT-003
    • (no location specified)
    Nov 21, 2022

    OCT Angiography in Wet AMD

    Recruiting
    • Neovascular (Wet) Age-related Macular Degeneration (AMD)
    • Optical Coherence Tomography
    • Portland, Oregon
      Casey Eye Institute, Oregon Health & Science University
    Sep 20, 2022

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Diabetic Macular Edema
    • Los Angeles, California
    • +11 more
    Jan 11, 2023

    Photodynamic Therapy for PDA in NV AMD

    Completed
    • Neovascular Age-related Macular Degeneration
    • Macular Degeneration
    • No Intervention
    • Durham, North Carolina
      Duke Eye Center
    Nov 8, 2021

    Neovascular Age-related Macular Degeneration Trial in Oslo (Zoledronic Acid 5 MG in 5 ML Injection, Placebos)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Zoledronic Acid 5 MG in 5 ML Injection
    • Placebos
    • Oslo, Norway
    • +1 more
    Jan 12, 2022

    Retinal Revascularization and Clinical Indicators of Neovascular

    Recruiting
    • Wet Macular Degeneration
    • Ophthalmic Drugs
    • Arendal, Agder, Norway
      Sorlandet Hospital HF
    Mar 3, 2022

    Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

    Completed
    • Neovascular Age-related Macular Degeneration
    • Phoenix, Arizona
    • +10 more
    Dec 1, 2022

    Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, Macular Degeneration Trial in Czechia, Poland, Slovakia

    Recruiting
    • Wet Macular Degeneration
    • +2 more
    • Brno, Czechia
    • +15 more
    Jan 25, 2023

    Neovascular Age-related Macular Degeneration

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Neovascular Age-related Macular Degeneration Trial in Seoul (Eylea, ALT-L9)

    Completed
    • Neovascular Age-related Macular Degeneration
    • Eylea
    • ALT-L9
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jan 14, 2022

    Wet Age-related Macular Degeneration Trial in Hungary, Latvia, United States (Zimura, Lucentis)

    Completed
    Has Results
    • Wet Age-related Macular Degeneration
    • Phoenix, Arizona
    • +27 more
    Feb 3, 2022

    Neovascular Age-related Macular Degeneration

    Completed
    • Age-related Macular Degeneration (AMD)
    • East Hanover, New Jersey
      Novartis Pharmaceuticals
    Oct 19, 2021

    Ocular Adverse Events in Neovascular Agerelated Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

    Enrolling by invitation
    • Wet Age-related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • ADVM-022
    • Bakersfield, California
    • +8 more
    Dec 23, 2021

    Ocular Adverse Events in Neovascular Age-related Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021

    Macular Degeneration, Wet, Metamorphopsia Trial

    Recruiting
    • Macular Degeneration, Wet
    • Metamorphopsia
      • Cuneo, Piedmont, Italy
        Ospedale Santa Croce
      Sep 20, 2022

      Neovascular Age-related Macular Degeneration Trial in Shanghai (IBI302 (the first dose level), IBI302 (the second dose level),

      Completed
      • Neovascular Age-related Macular Degeneration
      • IBI302 (the first dose level)
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai General Hospital
      Nov 10, 2021

      Exudative Macular Degeneration Trial in Vienna (anti-VEGF agent)

      Recruiting
      • Exudative Macular Degeneration
      • anti-VEGF agent
      • Vienna, Austria
        Department of Ophthalmology, Medical University of Vienna, Austr
      Oct 13, 2021

      Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

      Active, not recruiting
      • Wet Age-related Macular Degeneration
      • Neovascular Age-related Macular Degeneration
      • ADVM-022
      • Bakersfield, California
      • +10 more
      Mar 21, 2022